Atin is a seasoned Pharmacovigilance expert with over 18 years of diverse global experience. He has accumulated over 14 years of expertise in Pharmacovigilance (including Medical Devices), contributing to major pharmaceutical companies such as Eli Lilly, Novartis, GSK, Haleon, Samsung Bioepis, and UK regulatory authority MHRA.

Dr Rishi Verma: Rishi is the Director of Stethy, an AI platform that automates workflows in the life science. An accomplished Physician by background, Rishi led a number of pharmacovigilance and clinical trial programs of the life sciences. Ms Catherine Rillo Catherine is the Patient Safety Lead at Roche. Pharmacovigilance professional with leadership experience. She has 10+ years of pharmaceutical industry experience, specialising in pharmacovigilance activities. Initially working on core PV activities such as case processing, health authority submissions and compliance activities and across the many years, have stretched experience to consulting on local Business projects and Global initiatives.

Phil is the Deputy Director of Patient Safety Monitoring within MHRA’s Safety & Surveillance function and has over eighteen years of experience working in pharmacovigilance. Prior to his current role Phil spent fourteen years leading and developing the pharmacovigilance system, including technology, processes, and relevant aspects of Pharmacovigilance Legislation. He is now accountable for Patient Safety Monitoring across medicines, vaccines, devices, defects and blood products. Phil was responsible delivery of MHRA systems for COVID-19 vaccine surveillance and their integration into the healthcare system. For several years he has led international projects to develop and deliver tools for global pharmacovigilance.